Taurursodiol

31 interactions 3 explained in plain English

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Cyclosporine Injection Clindamycin Topical Abemaciclib Olaparib Axitinib Dasatinib

31 Major

All (31) Major (31)

Major

Taurursodiol Clindamycin ANTIROBE Explained Decreased exposure of the CYP3A4 substrate Details Taurursodiol Colchicine Colcrys Explained Increased exposure of the P-gp substrate Details Taurursodiol Abemaciclib Verzenio Explained Decreased exposure of the CYP3A4 substrate Details Taurursodiol Acalabrutinib Calquence Decreased exposure of the CYP3A4 substrate Details Taurursodiol Axitinib Inlyta Decreased exposure of the CYP3A4 substrate Details Taurursodiol Bosutinib Bosulif Decreased exposure of the CYP3A4 substrate Details Taurursodiol Brigatinib Alunbrig Decreased exposure of the CYP3A4 substrate Details Taurursodiol Cholestyramine Resin Locholest® Reduced exposure of taurursodiol Details Taurursodiol Clindamycin Injection ANTIROBE Decreased exposure of the CYP3A4 substrate Details Taurursodiol Clindamycin Topical C/T/S® Decreased exposure of the CYP3A4 substrate Details Taurursodiol Clindamycin Vaginal Cleocin Decreased exposure of the CYP3A4 substrate Details Taurursodiol Cobimetinib Cotellic Decreased exposure of the CYP3A4 substrate Details Taurursodiol Colesevelam Welchol Reduced exposure of taurursodiol Details Taurursodiol Colestipol Colestid Reduced exposure of taurursodiol Details Taurursodiol Cyclosporine Injection Atopica Serious toxicities or loss of efficacy Details Taurursodiol Cyclosporine Ophthalmic Cequa Serious toxicities or loss of efficacy Details Taurursodiol Dasatinib Phyrago Decreased exposure of the CYP3A4 substrate Details Taurursodiol Digoxin Cardoxin® Increased exposure of the P-gp substrate Details Taurursodiol Dihydroergotamine Injection DHE-45® Injection Decreased exposure of the CYP3A4 substrate Details Taurursodiol Dihydroergotamine Nasal Spray Migranal Decreased exposure of the CYP3A4 substrate Details Taurursodiol Docetaxel Beizray Decreased exposure of the CYP3A4 substrate Details Taurursodiol Docetaxel Injection Beizray Decreased exposure of the CYP3A4 substrate Details Taurursodiol Dofetilide Tikosyn Decreased exposure of the CYP3A4 substrate Details Taurursodiol Entrectinib Rozlytrek Decreased exposure of the CYP3A4 substrate Details Taurursodiol Everolimus Afinitor Decreased exposure of the CYP3A4 substrate Details Taurursodiol Fentanyl Transdermal Patch Duragesic® Decreased exposure of the CYP3A4 substrate Details Taurursodiol Gemfibrozil Lopid Increased sodium phenylbutyrate/taurursodiol exposure Details Taurursodiol Mexiletine Mexitil® Decreased exposure of the CYP1A2 substrate Details Taurursodiol Midostaurin Rydapt Decreased exposure of the CYP3A4 substrate Details Taurursodiol Neratinib Nerlynx Decreased exposure of the CYP3A4 substrate Details Taurursodiol Olaparib Lynparza Decreased exposure of the CYP3A4 substrate Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.